Results 91 to 100 of about 1,887 (161)

Evaluation of the extracellular and intracellular activities (human THP-1 macrophages) of telavancin versus vancomycin against methicillin-susceptible, methicillin-resistant, vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus

, 2006
OBJECTIVES: To compare extracellular and intracellular activities of telavancin (versus vancomycin) against Staphylococcus aureus (MSSA, MRSA, VISA and VRSA).
Barcia Macay, Maritza, Van Bambeke, Françoise, Mingeot-Leclercq, Marie-Paule, Tulkens, Paul M., Lemaire, Sandrine   +4 more
core   +1 more source

Evidence based approach to the treatment of community-associated methicillin-resistant Staphylococcus aureus

Infection and Drug Resistance, 2009
William J Peppard1, Anne Daniels1, Lynne Fehrenbacher2, Jamie Winner31Froedtert Hospital Milwaukee, Wisconsin, USA; 2Aurora St Luke’s Medical Center Milwaukee, Wisconsin, USA; 3Clement J Zablocki VA Medical Center, Milwaukee, Wisconsin ...
William J Peppard, Anne Daniels, Lynne Fehrenbacher, Jamie Winner   +3 more
doaj  

MIC data for defensin 1, telavancin and daptomycin alone and in combination against MRSA strain MW2.

, 2015
MIC data for defensin 1, telavancin and daptomycin alone and in combination against MRSA strain MW2.
Frederick M. Ausubel (105848), Eleftherios Mylonakis (24103), Tatiana Johnston (753006), Rajmohan Rajamuthiah (524532), Elamparithi Jayamani (524533), Andreas Vilcinskas (68058), Beth Burgwyn Fuchs (24099), Wooseong Kim (408076), Annie L. Conery (159554)   +8 more
core   +1 more source

Studies on the mechanism of telavancin decreased susceptibility in a laboratory-derived mutant

, 2013
Telavancin is a novel semisynthetic lipoglycopeptide derivative of vancomycin with a dual mode of action. This study sought to understand the mechanisms of decreased telavancin susceptibility in a laboratory-derived Staphlococcus aureus mutant Tlv<sup&
Wilkinson, BJ, Benton, BM, Lunde, CS, Song, Y   +3 more
core   +1 more source

Vancomycin-resistant enterococcal infections: epidemiology, clinical manifestations, and optimal management

Infection and Drug Resistance, 2015
Tristan O’Driscoll,1 Christopher W Crank2 1Department of Pharmacy Practice, Chicago College of Pharmacy, Downers Grove, IL, USA; 2Pharmacy Services, Rush-Copley Medical Center, Aurora, IL, USA Abstract: Since its discovery in England and France in
O’Driscoll T, Crank CW
doaj  

The efficacy of telavancin in comparison with linezolid on endotracheal tube biofilm in pigs with methicillin-resistant Staphylococcus aureus pneumonia

Background: The effect of systemic treatment of ventilator-associated pneumonia (VAP) with telavancin, a semisynthetic lipoglycopeptide with good penetration in vitro biofilms, has not been tested in vivo during mechanical ventilation.
Bassi G. L., Soler-Comas A., Motos A., Fernandez-Barat L., Torres A., Bueno-Freire L., Kiarostami K., Battaglini D.   +7 more
core   +1 more source

In vitro activity of newer antimicrobials against penicillin non-susceptible strains of Streptococcus pneumoniae

Infection and Drug Resistance, 2019
Marlene Hipp, Irene BurckhardtDepartment for Infectious Diseases, Microbiology and Hygiene, University Hospital of Heidelberg, Heidelberg, GermanyBackground: Since the first isolation of Streptococcus pneumoniae with low penicillin susceptibility in the ...
Hipp M, Burckhardt I
doaj  

In vivo tolerability of topical telavancin versus vancomycin in a murine ocular model. [PDF]

J Antimicrob Chemother
Fenniri I, Bispo PJM, Andre C.
europepmc   +1 more source

Current Recommendations, Antibiotic Resistance, and Emerging Treatments for Gram-Positive Ocular Infections in the United States. [PDF]

Antibiotics (Basel)
Fenniri I, André C.
europepmc   +1 more source

Efficacy and safety of vancomycin versus 13 alternatives in MRSA-confirmed skin and soft tissue infections: a meta-analysis of 39 randomized controlled trials. [PDF]

Infection
Purja S, Elghanam Y, Kim E.
europepmc   +1 more source